Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

Washington Research Foundation awards $7M to UW Institute for Protein Design to advance AI-enabled enzyme development

March 20, 2026
Vol.52 No.11
Vasan Yegnasubramanian: How AI is transforming cancer research and treatment
Sponsored

Vasan Yegnasubramanian: How AI is transforming cancer research and treatment

March 06, 2026
Vol.52 No.09
By John’s Hopkins Kimmel Cancer Center Communications
Clinical Roundup

AI-based liquid biopsy may detect liver fibrosis, cirrhosis, and broader chronic disease signals, Johns Hopkins researchers find

March 06, 2026
Vol.52 No.09
Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era
Podcast

Lawsuits brought against Tempus AI raise more questions than answers about DNA privacy in the AI era

March 04, 2026
Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE

Two lawsuits vs. Tempus raise questions about privacy of germline data in cancer RWE
“Deidentified” ≠ “deidentifiable”

February 27, 2026
Vol.52 No.08
By Paul Goldberg
Drugs & Targets

PharmaMar, Globant collaborate to accelerate oncology research with AI

February 20, 2026
Vol.52 No.07
Clinical Roundup

AI tool may help personalize ovarian cancer treatment from day one

February 13, 2026
Vol.52 No.06
Clinical Roundup

Most patients support use of AI to help read mammograms with doctor oversight, UTSW survey finds

January 30, 2026
Vol.52 No.04
Drugs & Targets

ACR names University Hospital of Bern first international ARCH AI Site

January 30, 2026
Vol.52 No.04
Cancer Policy

FDA releases 10 guiding principles for AI use in drug development

January 16, 2026
Vol.52 No.02
By Sara Willa Ernst

Posts navigation

Previous123…16Next

Trending Stories

  • “Backwater to Blockbuster” chronicles the previously untold story of the explosive growth of St. Jude Children’s Research Hospital
    In a conversation with Deborah Doroshow, co-authors Chuck Sherr and Bill Evans discuss their collaborative writing process
  • DOJ alleges that Yale and UCLA discriminated based on race in medical school admissions
  • FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
    “Patients are owed another review.”
  • How City of Hope is turning microbiome science into better cancer care
  • Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
  • FDA clears fruit-flavored vapes, relaxes enforcement on black-market products with pending premarket applications
    Critics say policies clear the way for major tobacco companies to enter fruit-flavored vape market

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2026 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account